TotalSeq™-B0008 anti-human CD273 (B7-DC, PD-L2) Antibody, CD273, 24F.10C12,BioLegend,329625

Host

Mouse

Reactivity

Human

Application

PG -Quality tested

Platform ID

BAB548416158

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameTotalSeq™-B0008 anti-human CD273 (B7-DC, PD-L2) Antibody, CD273, 24F.10C12
Cat. No.329625
HostMouse
RRIDAB_2832647 (BioLegend Cat. No. 329625)
IsotypeMouse IgG2a, κ
ReactivityHuman
ApplicationPG -Quality tested
ClonalityMonoclonal
Clone Number24F.10C12
Concentration0.5 mg/mL
TargetCD273
ImmunogenHuman PD-L2 cDNA
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-B oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

CD273, known as B7-DC, is also called programmed death ligand 2 (PDL2). This ligand is a 25 kD type I transmembrane protein and a member of B7 family within the immunoglobulin receptor superfamily and is expressed on a subset of dendritic cells, liver and a small subset of macrophages as well as a few transformed cell lines. CD273 has been reported to be stimulatory on dendritic cells when cross-linked and to inhibit T cell activation upon engaging the PD-1 receptor. CD273 has also been reported to bind to an alternative receptor and to mediate T cell activation through such non-PD1 mediated interactions.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.